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Abstract
Objective: To study lesions in the oral cavity of patients with hereditary hemochromatosis and determine their 
association with iron overload.
Study Design: We took a clinical history, examined the pigmentation of the oral mucosa, and measured total 
stimulated saliva production. We correlated our results with epidemiological, phenotypic, and genotypic findings. 
Patients with associated diseases or drug therapy causing xerostomia were excluded. 
Results: We evaluated 25 patients (20 men, mean age 52 years) over a period of 6 months. No patient complained 
of xerostomia and pigmentation was not detected in the oral mucosa. The total stimulated salivary flow was re-
duced in 9 patients who had an average ferritin level of 796.5 µg/l. The decline in total stimulated salivary flow 
was significantly correlated with ferritin levels (p=0.002). Patients with ferritin levels within the normal range 
also had normal stimulated salivary flow.
Conclusions: We found no pigmented lesions in the oral mucosa; however, we did observe a decrease in total 
stimulated salivary flow that correlated with ferritin levels. Therefore, hyposialia caused by functional impair-
ment of the salivary glands may be an early marker of iron deposition. 
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Introduction
Hereditary hemochromatosis (HH) is an autosomal 
recessive disease characterized by increased intestinal 
absorption of dietary iron, which progresses to overload 
and slow and progressive deposition of iron in various 
organs. This in turn leads to tissue damage with struc-
tural abnormalities (fibrosis) and functional abnormali-
ties (cirrhosis, cardiomyopathy, diabetes, arthropathy, 
osteoporosis, skin pigmentation, and hypogonadism) 
(1). However, diagnosis of HH is increasingly based on 
laboratory findings and not on clinical criteria. Further-
more, in asymptomatic patients or patients with non-
specific symptoms such as fatigue or arthralgia, hyper-
pigmentation is not generally an early clinical sign (2). 
Oral manifestations are not usually recorded as signs 
or symptoms, especially if no skin hyperpigmentation 
is present (3). The absence of specific clinical manifes-
tations appears to be more related to early diagnosis, 
the presence of iron overload (mild or moderate), and 
the absence of serious complications such as cirrhosis. 
Skin and mucosal manifestations have been described 
in highly developed clinical forms (1). 
The classic clinical presentation of HH with iron over-
load is associated with mutations in the HFE gene, 
namely, C282Y and/or H63D. C282Y is more common 
in northern Europe; H63D is more common in south-
ern Europe, including Spain, and causes less severe 
disorders. In addition to the primary clinical or genetic 
form, secondary iron overload can be observed, mainly 
in patients undergoing multiple transfusions, with clini-
cal manifestations that sometimes overlap with those of 
HH (4). Although also an acute phase reactant, serum 
ferritin is used to assess iron stores in the body; higher 
values indicate iron overload and can be used to assess 
associated risk (2). Thus, lesions of the oral mucosa and 
alterations in salivary flow (5, 6) have traditionally been 
studied in patients with elevated iron deposits, severe 
organ involvement (mainly the liver), and skin hyper-
pigmentation, with high ferritin values indicating se-
vere iron overload (7-9). We studied manifestations in 
the oral mucosa and salivary flow in patients with HH 
in a unit dedicated to early diagnosis and genetic coun-
seling of patients with this disease. Related disorders 
of the oral cavity were examined in terms of organ in-
volvement, genotype, and degree of iron overload. The 
objectives of this study were to detect the presence of 
pigmentation in the oral mucosa of patients with HH 
and to determine whether there was a relationship be-
tween levels of iron overload and total stimulated sali-
vary flow (SSF) (5-7).
Materials and Methods
This prospective cross-sectional study was conducted 
from October 2009 to March 2010. The study sample 
comprised patients diagnosed with HH in the Iron Dis-
orders Unit of Hospital General Universitario Gregorio 
Marañón (Madrid, Spain) and first-degree relatives of 
these patients. We excluded patients with associated 
diseases and/or those receiving medication that could 
alter salivary flow (10). 
The study was designed and conducted in accordance 
with the principles of the Declaration of Helsinki (2008) 
and local ethics requirements. Prior to implementation, 
all patients gave their informed consent to participate. 
The pigmentation of the oral mucosa was examined and 
total SSF was determined using sialometry. We collect-
ed epidemiological data and data on general and specif-
ic oral symptoms. Patients who replied positively to the 
question “are you normally aware of your dry mouth?” 
were considered to have xerostomia (11,12). We evalu-
ated the presence of associated diseases, general and 
specific drug therapy that could potentially cause xeros-
tomia, phenotype (ferritin levels), and genotype (study 
of C282Y and H63D in the HFE gene). The physical 
examination revealed the condition of the labial, lin-
gual, gingival, and buccal mucosa. SSF was assessed 
by asking the patient to chew on a piece of paraffin for 
one minute. The patient then swallowed the paraffin and 
the saliva generated during the following five minutes 
was collected and measured using a stopwatch and a 
pipette (13). The patient was given general instructions 
and asked not to eat, smoke, or chew gum during the 90 
minutes before the test. The same person collected saliva 
samples under the same conditions between 12:00 and 
14:00 to minimize the influence of circadian rhythms 
(14). Due to the large variation in SSF between subjects, 
it is difficult to establish the cutoff for normal values. 
However, 1 to 2 ml/min is generally considered a nor-
mal rate (15,16). Hammarén and Hugoson (17) observed 
a reduction in SSF, with an average of 0.9 ml/min. In 
our study, reduced SSF was considered to be that fall-
ing below the first tertile (<0.8 ml/min). The statistical 
analysis was performed using SPSS ® 16. The Mann-
Whitney test was applied for two independent samples. 
Statistical significance was set at ≤0.05.
Results
The study sample comprised 25 patients (20 men; mean 
[SD] age, 52 [13.1] years), none of whom reported suf-
fering from xerostomia. Pigmented lesions were not de-
tected in the oral mucosa in any patients. The mean (SD) 
ferritin level was 475.4 (387.5) µg/l (normal range 26-370 
μg/l), ranging from 38 to 1543 (Table 1). Mean total SSF 
was 1.5 (1.2) ml/min. Decreased flow was detected in 9 
patients (36%) (Table 1). Patients with reduced SSF had 
ferritin levels above 266 µg/l (mean, 796.5 µg/l) and a 
mean SSF of 0.68 ml/min (Fig. 1). In patients with a nor-
mal salivary function, we observed a flow of 2 ml/min, 
and a mean level of ferritin 294.7 µg/l (Table 2). All pa-
tients with normal ferritin levels had a preserved SSF. 
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Fig. 1. Salivary secretion and normal and decreased ferritin levels.
Table 1. Characteristics of the 25 cases of hereditary hemochromatosis.

 
Case 
 
Age 
(year) 
 
Sex 
 
 
Decreased 
salivary flow  
Pigmentation 
 
 
Ferritin 
(ȝg/l) 
 
Secretion 
(ml/min) 
 
Genotype HFE(1) 
 
1 74 Male YES NO 829 0.7 Negative 
2 57 FEMALE NO NO 617 1.8 H63D/H63D 
3 49 FEMALE YES NO 266 0.8 C282Y/H63D 
4 64 MALE NO NO 683 2 H63D/– 
5 74 MALE YES NO 569 0.8 H63D/– 
6 39 MALE NO NO 201 1.6 C282Y/C282Y 
7 31 MALE NO NO 541 1.2 C282Y/– 
8 39 MALE NO NO 89 1.6 C282Y/H63D 
9 67 MALE NO NO 423 6 H63D/– 
10 61 MALE NO NO 235 1.2 C282Y/C282Y 
11 37 FEMALE NO NO 280 1.8 C282Y/H63D 
12 45 MALE NO NO 38 4 C282Y/C282Y 
13 46 MALE NO NO 104 1.6 Negative 
14 54 FEMALE YES NO 853 0.6 C282Y/H63D 
15 53 MALE NO NO 125 2.4 C282Y/H63D 
16 61 MALE YES NO 610 0.6 H63D/– 
17 66 MALE NO NO 100 1.2 C282Y/H63D 
18 49 MALE NO NO 76 2 Negative 
19 39 MALE NO NO 334 2 C282Y/C282Y 
20 34 MALE YES NO 321 0.6 C282Y/H63D 
21 52 MALE NO NO 518 2 H63D/H63D 
22 29 FEMALE NO NO 352 1 C282Y/H63D 
23 60 MALE YES NO 1380 0.7 Negative 
24 67 MALE YES NO 798 0.6 H63D/– 
25 51 MALE YES NO 1543 0.8 H63D/– 
 Mean 
52 
 
 
Male/Female 
20/5 
80%/ 20% 
 
Yes/No 
9/16 
36%/ 64% 
 
25 
 
 
 
 
Mean 
475.4 
 
 
Mean 
1.5 
 
 
(1) 
 
 
 
(1): Study of mutations C282Y and H63D in the HFE gene 
      C282Y/H63D: compound heterozygosity
      C282Y/–, H63D/–: heterozygosity 
      C282Y/C282Y, H63D/H63D: homozygosity
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Analysis by gender revealed a mean age for men of 53 
(12.8) years, a ferritin level of 501 µg/l and a total SSF 
of 1.7 ml/min. Seven men had a mean ferritin level of 
864.2 µg/l, with a mean flow of 0.68 ml/min. Patients 
with normal total SSF had a mean ferritin level of 306.4 
µg/l, and a mean flow of 2.2 ml/min (Table 2). The mean 
age of the 5 women studied was 47 (14.4) years. Ferritin 
level was 370 µg/l, and salivary flow 1.08 ml/min. Two 
women had hyposialia (559.5 µg/l), with a discharge of 
0.7 ml/min. Patients with normal salivary flow had a 
ferritin level of 244 µg/l and a discharge of 1.3 ml/min. 
We compared mean ferritin levels in patients with hy-
posialia with those of subjects with normal salivary 
flow using the nonparametric Mann-Whitney test (the 
sample was smaller than 30 individuals). The difference 
was statistically significant (p = 0.002) (Table 2). The 
study of the C282Y and H63D mutations in the HFE 
gene in 9 patients with iron overload and hyposialia re-
vealed 4 patients with a heterozygous genotype H63D 
and 3 cases with compound heterozygosity C282Y/
H63D. The remaining 2 did not show any mutations in 
the HFE gene (Table 1).
Table 2. Association between SSF and ferritin level, and sex, expressed as mean (SD).
SSF decreased SSF normal Mann-Whitney 
TOTAL
n 9 16  
p=0.002 
Age 58.2 (12.8) 48.3 (12.2) 
Ferritin 
(µg/l)
796.5 (432.4) 294.7 (209.4) 
Salivary flow 
(ml/min) 
0.68 (0.09) 2 (1.2) 
MALE
N 7 13  
p=0.005 Age 60.1 (14.1) 49.3 (10.9) 
Ferritin 
(µg/l)
864.2 (443.3) 306.4 (226.3) 
Salivary flow 
(ml/min) 
0.68 (0.08) 2.2 (1.3) 
FEMALE
n 2 3  
p=0.8 Age 51.5 (3.5) 44 (19.4) 
Ferritin 
(µg/l)
559.5 (415) 244 (129.8) 
Salivary flow 
(ml/min) 
0.7 (0.1) 1.3 (0.4) 
SSF, stimulated salivary flow.
Discussion
Our patients showed no pigmentation in the oral mu-
cosa, although the frequency of this finding has been 
estimated to be between 15% and 20% (8, 9). We at-
tribute this lack of pigmentation to the small sample 
size and the fact that our patients had mild or moderate 
iron overload, with no associated diseases. However, in 
9 patients, we observed that SSF had fallen, as reported 
elsewhere (6), in patients with no organic, functional, or 
pharmacological causes of hyposialia (mainly psycho-
active parasympatholytics, antihypertensives) (10). No 
patients presented xerostomia, and, in cases in which 
hyposialia was demonstrated, the most likely cause may 
be metabolic in origin, namely sialosis caused by iron 
deposition in parenchymal cells, as reported elsewhere 
(6,7). None of our patients had the classic genotype, 
homozygous C282Y, whereas heterozygous H63D (4 
cases) and compound heterozygosis (3 cases) predomi-
nated. No mutations were found in the 2 remaining ca-
ses. The Mann-Whitney test revealed a p value of 0.002, 
thus justifying the conclusion that there are significant 
differences in ferritin levels in patients with reduced 
and normal salivary flow. Given the limitations of the 
sample size and the characteristics of patients with mild 
or moderate iron overload, future studies with larger 
sample sizes should be performed to assess the outcome 
of patients without iron overload undergoing phleboto-
my and to study whether SSF values return to normal. 
Therefore, this condition seems to involve a reversible 
functional impairment that improves after phlebotomy 
and normalization of ferritin levels. Takeda and Ohya 
(7) reported a case of hemochromatosis secondary to 
iron injection and blood transfusion—evident from 
the iron deposits in the salivary glands—together with 
xerostomia that disappeared after treatment with defer-
oxamine (parenteral iron chelator), thus demonstrating 
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the reversibility of the process. If our hypothesis that the 
decrease in SSF is reversible and related to iron overload 
is confirmed, we propose that this marker is associated 
with other markers of iron overload and should be used 
as a clinical criterion of disease progression.
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